Literature DB >> 19056614

Anemia and risk of hospitalization in pediatric chronic kidney disease.

Amy O Staples1, Craig S Wong, Jodi M Smith, Debbie S Gipson, Guido Filler, Bradley A Warady, Karen Martz, Larry A Greenbaum.   

Abstract

BACKGROUND AND OBJECTIVES: Anemia is a well known complication of chronic kidney disease (CKD); however, the prevalence of anemia within CKD stages in the pediatric population has not been established. Additionally, the associated morbidity of anemia in the pediatric CKD population has not been elucidated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: 2,779 patients ages 2 yr and older in the North American Pediatric Renal Trials and Collaborative Studies database with CKD stage II to V (excluding dialysis or previous transplant patients) were identified. Descriptive statistics and multivariate modeling using logistic regression was performed to determine the prevalence of anemia and to evaluate the correlation between baseline anemia and hospitalization.
RESULTS: The prevalence of anemia (hematocrit < 33%) increased from 18.5% in CKD stage II to 68% in CKD stage V (predialysis). Anemic children were 55% more likely to be hospitalized when compared with nonanemic children (odds ratio 1.55; 95% confidence interval 1.23 to 1.94). Similar results were obtained using hematocrit cutoffs of 36 and 39%.
CONCLUSIONS: In this pediatric predialysis CKD population, anemia increases with increasing CKD stage and is significantly associated with hospitalization risk. Hematocrit levels above 36 and 39% were not associated with increased risk of hospitalization. Further examination into the effect of correcting anemia on hospitalization rates may provide additional useful information.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056614      PMCID: PMC2615713          DOI: 10.2215/CJN.05301107

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  21 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

3.  KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.

Authors: 
Journal:  Am J Kidney Dis       Date:  2007-09       Impact factor: 8.860

4.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

5.  Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure.

Authors:  M Chandra; G K Clemons; M I McVicar
Journal:  J Pediatr       Date:  1988-12       Impact factor: 4.406

6.  Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis.

Authors:  G Montini; G Zacchello; E Baraldi; S Zanconato; A Suppiej; F Fabris; B Andreetta; L Pavanello; F Zacchello
Journal:  J Pediatr       Date:  1990-10       Impact factor: 4.406

7.  The prevalence of anemia in patients with chronic kidney disease.

Authors:  William McClellan; Stephen L Aronoff; W Kline Bolton; Sally Hood; Daniel L Lorber; K Linda Tang; Thomas F Tse; Brian Wasserman; Marc Leiserowitz
Journal:  Curr Med Res Opin       Date:  2004-09       Impact factor: 2.580

8.  Low-dose subcutaneous recombinant erythropoietin in children with chronic renal failure. Australian and New Zealand Paediatric Nephrology Association.

Authors:  J R Burke
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

9.  Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.

Authors:  R J McGonigle; F G Boineau; B Beckman; K Ohene-Frempong; J E Lewy; R K Shadduck; J W Fisher
Journal:  J Lab Clin Med       Date:  1985-04

Review 10.  Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences.

Authors:  Kamyar Kalantar-Zadeh; T Alp Ikizler; Gladys Block; Morrel M Avram; Joel D Kopple
Journal:  Am J Kidney Dis       Date:  2003-11       Impact factor: 8.860

View more
  24 in total

1.  Why multidisciplinary clinics should be the standard for treating chronic kidney disease.

Authors:  Guido Filler; Steven E Lipshultz
Journal:  Pediatr Nephrol       Date:  2012-07-04       Impact factor: 3.714

2.  Effects of changes in adult erythropoietin dosing guidelines on erythropoietin dosing practices, anemia, and blood transfusion in children on hemodialysis: findings from North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS).

Authors:  Sarah A Twichell; Elizabeth A K Hunt; Karen Martz; Michael J G Somers
Journal:  Pediatr Nephrol       Date:  2019-11-10       Impact factor: 3.714

3.  Association between clinical risk factors and progression of chronic kidney disease in children.

Authors:  Amy O Staples; Larry A Greenbaum; Jodi M Smith; Debbie S Gipson; Guido Filler; Bradley A Warady; Karen Martz; Craig S Wong
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 8.237

Review 4.  Cardiovascular complications in children with chronic kidney disease.

Authors:  Rukshana Shroff; Donald J Weaver; Mark M Mitsnefes
Journal:  Nat Rev Nephrol       Date:  2011-09-13       Impact factor: 28.314

Review 5.  Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease.

Authors:  Bradley A Warady; Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2013-09-05       Impact factor: 3.714

6.  Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis.

Authors:  Rachel M Lestz; Barbara A Fivush; Meredith A Atkinson
Journal:  Pediatr Nephrol       Date:  2014-05-03       Impact factor: 3.714

7.  Iron deficiency in children with early chronic kidney disease.

Authors:  Rossana Baracco; Sermin Saadeh; Rudolph Valentini; Gaurav Kapur; Amrish Jain; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2011-06-28       Impact factor: 3.714

Review 8.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

Review 9.  Risk factors for progression of chronic kidney disease.

Authors:  Amy Staples; Craig Wong
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

10.  Association between common iron store markers and hemoglobin in children with chronic kidney disease.

Authors:  Meredith A Atkinson; Christopher B Pierce; Jeffrey J Fadrowski; Nadine M Benador; Colin T White; Martin A Turman; Cynthia G Pan; Alison G Abraham; Bradley A Warady; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2012-07-27       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.